Category Archives: Brain Injury Treatment

The public comments portion at the meetings of the Coweta County Commission often center on specifically local issues and concerns. But the comments of 26-year-old Coweta County resident Lindsey Bush at the June 5 meeting felt more like a call to arms for someone determined to make a change in the state and federal system. As someone who suffered traumatic brain injury (TBI) more than a decade ago and has completed an undergraduate degree, Lindsey called on the commission to support her efforts to have TBI individuals accepted under the Americans with Disabilities Act. Articulate in her comments to the commission, Lindsey explained her situation and her mission. Lindsey is now 26 years old. At age 15 she was involved in a traffic accident that left her comatose for nine months. She came out of the coma but faced what many people would consider insurmountable odds for any kind of recovery. The right side of my body was paralyzed, including my vocal cords. My lungs collapsed, my ribs were broken, my pelvis was shattered, and my brain sheared internally along the pons, corpus callosum, medulla and cerebellum regions, Bush said, describing her injuries. I had no hope to live and … Continue reading →

Public release date: 15-Jun-2012 [ | E-mail | Share ] Contact: Leslie Shepherd shepherdl@smh.ca 416-864-6094 St. Michael's Hospital TORONTO, June 15, 2012St. Michael's Hospital has been awarded up to $700,000 from the Federal Economic Development Agency of Southern Ontario to investigate new treatments to prevent complications following certain brain injuries. The funding, to be administered by the Ontario Brain Institute, is part of an $11 million package announced by the federal government to help accelerate the commercialization of neurotechnologies. The FedDev funds will be matched by Edge Therapeutics, Inc., a biopharmaceutical company based in New Jersey. Edge and St. Michael's are exploring new ways of delivering nimodipine, an oral drug that has shown good results in preventing vasospasm, a major complication of aneurismal subarachnoid hemorrhage (bleeding in the area between the brain and the thin tissue that covers the brain). For two weeks following a subarachnoid hemorrhage, patients are susceptible to cerebral vasospasm, which limits blood flow to the brain and can cause ischemic strokes and additional tissue damage. Nimodipine inhibits calcium ion transfer into smooth muscle, thus preventing contraction of smooth vascular muscle in the brain. Subarachnoid hemorrhage affects 10 in 100,000 people in North America each year, or … Continue reading →

FORT BELVOIR, Va. Air Force Master Sgt. Earl Covel had gone through just about every treatment anyone could think of for the brain injuries he sustained over his 12 deployments even the hyberbaric chamber. Nothing seemed to be working very well. They were just throwing spears, doing the best they could, he said. Then a friend told him about the National Intrepid Center of Excellence at Bethesda, Md., a facility dedicated to the treatment, diagnosis and research of mild traumatic brain injury and psychological health issues. Covel was assigned an army of providers, he said, and his wife was encouraged to participate in the process. The team led Covel off a very dark path, he said. But while hundreds of thousands of combat veterans are suffering from brain injuries, the NICoE can only treat about 250 servicemembers a year. To help fill the gap, the Intrepid Fallen Heroes Fund, which funded and built the NICoE, has embarked on a $100 million fundraising campaign to build at least nine NICoE satellite centers at bases around the country. On Wednesday, officials broke ground on the first two at Fort Belvoir near Washington and at Camp Lejeune in North Carolina. The satellite centers … Continue reading →

http://www.armytimes.com/news/2012/06/military-brain-injury-tied-to-malaria-drug-doctor-says-061312/ An Army physician who spent his career studying the malaria drug mefloquine, also known as Lariam, asked Congress on June 6 to support research on brain injuries he says can be caused by the medication. Speaking before the Senate Appropriations Committee, Maj. Remington Nevin requested funding for a mefloquine research center at a civilian medical or public health school to investigate the physiology, epidemiology, clinical diagnosis and treatment of health issues related to mefloquine. Given our research commitments to post-traumatic stress and traumatic brain injury this observation calls for a similarly robust agenda into mefloquine neurotoxic brain injury to ensure that patients with these conditions are receiving accurate diagnoses and the very best medical care, Nevin said. An epidemiologist and preventive medicine expert, Nevin published a case study in March of a sailor who developed psychosis, short-term memory loss, confusion and personality change after taking mefloquine. Nevin believes the drug caused lesions to form in the patients brain stem. He has published previous work similarly raising concerns about mefloquine, developed under the Armys malaria drug discovery program from 1963 to 1976 to prevent and treat malaria. Anecdotal reports of severe mefloquine reactions abound, including one presented in May at … Continue reading →

HERNDON, Va., June 12, 2012 /PRNewswire/ --BHR Pharma's SyNAPSe clinical trial is now enrolling patients suffering from severe traumatic brain injury (TBI) at 14 sites in Thailand, China and Russia. The trial currently has 153 participating sites (Level 1 and 2 trauma centers) worldwide. The 500th of 1,180 patients needed to complete the global Phase III, multi-center trial was enrolled at the end of May in the United States. SyNAPSe is evaluating the effectiveness of BHR-100, a proprietary intravenous progesterone infusion formulation, as a neuroprotective agent for treating severe TBI patients. The U.S. Food and Drug Administration had granted Orphan Drug designation to BHR-100 and have placed the drug on a Fast Track status designed to accelerate its potential approval. "In the past four months we've added 28 clinical trial sites, including additional centers in the United States and Europe, and we're working towards opening six Malaysian sites in the near future," said Thomas W. MacAllister, JD, PhD, President & CEO of BHR Pharma. "We're on track to complete enrollment for this pivotal clinical trial early next year, with the intent of bringing the first-ever treatment for TBI to market." TBI is a serious public health problem that affects more … Continue reading →

Newswise Researchers at the University of Missouri have demonstrated the effectiveness of a potential new therapy for stroke patients in an article published in the journal Molecular Neurodegeneration. Created to target a specific enzyme known to affect important brain functions, the new compound being studied at MU is designed to stop the spread of brain bleeds and protect brain cells from further damage in the crucial hours after a stroke. Stroke is a leading cause of death in the U.S. with more than 800,000 deaths occurring each year from stroke and other cardiac events. Other than surgery, existing emergency treatments for stroke victims such as the use of a tissue plasminogen activator (tPA) must be administered within hours of the stroke onset because of the risk for brain hemorrhaging. The injectable medication can only be used to treat the most common type of stroke that occurs when blood clots block blood flow to the brain, called ischemic stroke. "For a stroke victim, time is a matter of life and death. While we are still in the research phase for this type of compound, we believe it could be combined with tPA in the future to buy ischemic stroke patients a … Continue reading →

A MAN who left another man with a permanent brain injury by punching him once in the head has begged an Ipswich judge not to send him to jail. Samuel Mark Green, 40, was convicted by an Ipswich District Court jury after a two-day trial for grievous bodily harm after he punched a man, causing his head to hit the gutter, in the Ipswich CBD on December 8, 2010. The victim sustained a fractured skull, bleeding on his brain and a permanent change in personality. The court heard that if the man hadn't received hospital treatment, he would have died on the night of the attack. A victim impact statement tendered to the court said the man had sustained very real and lasting effects of the assault including a significant brain injury that made him more aggressive. Crown prosecutors said that by taking the case to trial, Green hadn't shown any remorse for his actions. Green's defence had argued the punch was inflicted in self-defence after the victim hit Green first. The barrister said his client hadn't been armed with a weapon and he genuinely didn't know one punch would have such devastating effects on the victim. Green asked to … Continue reading →

08-06-2012 18:55 Car Injury Compensation, Chiropractors in East Detroit Michigan, Dr. Chris McNeil. Phone (313) 884-5477 East Detroit Chiropractors, Car Accident Injury Claim 10575 Morang Drive Detroit, MI 48224 Metro Detroit Chiropractors Car Accident Injury Payment Chiropractors 48224. Link: Brain Damage Car Injury Claim East Detroit MI - Video … Continue reading →

08-06-2012 18:56 Car Injury Compensation, Chiropractors in East Detroit Michigan, Dr. Chris McNeil. Phone (313) 884-5477 East Detroit Chiropractors, Car Accident Injury Claim 10575 Morang Drive Detroit, MI 48224 Metro Detroit Chiropractors Car Accident Injury Payment Chiropractors 48224. Read this article: How Compensated Car Accident Injury Brain Damage East Detroit MI - Video … Continue reading →

08-06-2012 19:03 Car Injury Compensation, Chiropractors in East Detroit Michigan, Dr. Chris McNeil. Phone (313) 884-5477 East Detroit Chiropractors, Car Accident Injury Claim 10575 Morang Drive Detroit, MI 48224 Metro Detroit Chiropractors Car Accident Injury Payment Chiropractors 48224. Excerpt from: How Compensated Car Injury Brain Damage East Detroit MI - Video … Continue reading →